These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 74293)

  • 21. The role of humoral factors in the initiation of in vitro primary immune responses. IV. Are macrophages the adherent cell type required for cell cooperation.
    Watson J; Thoman M; Ralph P; Trenkner E
    J Immunol; 1974 May; 112(5):1873-83. PubMed ID: 4131877
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibody producers].
    Fischer H; Ax W; Malchow H
    Klin Wochenschr; 1969 Oct; 47(19):1019-25. PubMed ID: 4909977
    [No Abstract]   [Full Text] [Related]  

  • 23. Cooperation of normal and malignant lymphoid cells in the immune response against sheep erythrocytes.
    Boranić M; Hrsak I; Marotti T; Mazuran R; Silobrcić V
    Biomedicine; 1974 Jan; 21(1):9-12. PubMed ID: 4858487
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison between the dynamics of antibody production in the spleen and in the bone marrow].
    Vogelsang H; Noack H; Schäffner H
    Allerg Immunol (Leipz); 1973; 19(2-4):185-8. PubMed ID: 4281621
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune response in vitro of lymphocytes attached to macrophages and lymphocytes in suspension.
    Moulton JE; Gutierrez J
    Am J Vet Res; 1973 Jan; 34(1):119-23. PubMed ID: 4567362
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant effect of endotoxin; antibody response to sheep erythrocytes in mice after transfer of syngeneic lymphoid cells treated with bacterial lipopolysaccharide in vitro.
    Nakano M; Uchiyama T; Saito K
    J Immunol; 1973 Feb; 110(2):408-13. PubMed ID: 4567393
    [No Abstract]   [Full Text] [Related]  

  • 27. [Activation of DNA synthesis in splenic lymphoid cells in the inductive phase of primary immunological response].
    Maksimova GF; Babichev VA; Uteshev BS
    Vestn Akad Med Nauk SSSR; 1971; 26(11):67-73. PubMed ID: 5124700
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody against neoplastic plasma cells. II. Suppressive effect on antibody-producing cells.
    Watanabe T; Yagi Y; Pressman D
    J Immunol; 1971 Dec; 107(6):1706-13. PubMed ID: 4941114
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of repeated local stimulation on the splenic response to mucosal and parenteral immunization.
    André CI
    Dev Biol Stand; 1975; 28():237-45. PubMed ID: 1092574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis in vitro of tolerance.
    Forbes IJ
    Immunology; 1969 Jun; 16(6):699-706. PubMed ID: 5786940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the immune response of mouse spleen cells to sheep erythrocytes in vitro by anti-immunoglobulin sera.
    Sjöberg O; Greaves M
    Eur J Immunol; 1971 Jun; 1(3):157-62. PubMed ID: 4108346
    [No Abstract]   [Full Text] [Related]  

  • 32. [Autoradiographic study of the spleen at an early stage of the primary immune response].
    Maksimova GF; Babichev VA; Uteshev BS
    Dokl Akad Nauk SSSR; 1972 Dec; 207(6):1467-70. PubMed ID: 4643807
    [No Abstract]   [Full Text] [Related]  

  • 33. Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Pierce CW
    J Immunol; 1976 Sep; 117(3):967-72. PubMed ID: 1085315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP and immune responses. I. Influence of poly A:U and cAMP on antibody formation in vitro.
    Ishizuka M; Braun W; Matsumoto T
    J Immunol; 1971 Oct; 107(4):1027-35. PubMed ID: 4328591
    [No Abstract]   [Full Text] [Related]  

  • 35. The third cell type required for the immune response of spleen cells in vitro.
    Cosenza H; Leserman LD; Rowley DA
    J Immunol; 1971 Aug; 107(2):414-21. PubMed ID: 4936287
    [No Abstract]   [Full Text] [Related]  

  • 36. The potentiality of antibody-producing cells. II. Evidence for two antibody molecules of different specificities secreted by micromanipulated bispecific mouse spleen cells.
    Couderg J; Bleux C; Liacopoulos P
    Immunology; 1975 Oct; 29(4):665-74. PubMed ID: 52617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in the mouse. I. In vitro enhancement of antibody formation with normal spleen cells.
    Murgo AJ; Athanassiades TJ
    J Immunol; 1975 Oct; 115(4):928-31. PubMed ID: 170337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunossuppressive effects of Rauscher leukemia virus (RLV) upon spleen cells cultured in cell-impermeable diffusion chambers. 3. Inhibition of RLV-induced cell pathways by antigenic stimulation with hemocyanin.
    Borella L
    J Immunol; 1972 Jan; 108(1):45-53. PubMed ID: 5010396
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between the morphology of rosette-forming cells and their mode of rosette formation.
    Elson CJ; Allan D; Elson J; Duffus WH
    Immunology; 1972 Feb; 22(2):291-300. PubMed ID: 5062017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic competition between heterologous erythrocytes in mice. Immunological and histological studies exploring mechanisms of the antigenic competition.
    Ishikawa H; Mukai M; Mitsuma T; Saito K
    Immunology; 1977 May; 32(5):755-66. PubMed ID: 324903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.